Cytoreduction Surgical Procedures
"Cytoreduction Surgical Procedures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
| Descriptor ID |
D065426
|
| MeSH Number(s) |
E04.166
|
| Concept/Terms |
Cytoreduction Surgical Procedures- Cytoreduction Surgical Procedures
- Cytoreduction Surgical Procedure
- Procedure, Cytoreduction Surgical
- Surgical Procedure, Cytoreduction
- Debulking Surgical Procedures
- Debulking Surgical Procedure
- Procedure, Debulking Surgical
- Surgical Procedure, Debulking
- Cytoreductive Surgery
- Cytoreductive Surgeries
- Surgery, Cytoreductive
- Cytoreductive Surgical Procedures
- Cytoreductive Surgical Procedure
- Procedure, Cytoreductive Surgical
- Surgical Procedure, Cytoreductive
- Surgical Procedures, Cytoreductive
|
Below are MeSH descriptors whose meaning is more general than "Cytoreduction Surgical Procedures".
Below are MeSH descriptors whose meaning is more specific than "Cytoreduction Surgical Procedures".
This graph shows the total number of publications written about "Cytoreduction Surgical Procedures" by people in this website by year, and whether "Cytoreduction Surgical Procedures" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 5 | 5 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytoreduction Surgical Procedures" by people in Profiles.
-
ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 05; 30(5):3123-3124.
-
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3114-3122.
-
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840.
-
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 12; 29(Suppl 3):616-617.
-
Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC. J Gastrointest Surg. 2022 12; 26(12):2591-2594.
-
Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination. Am J Clin Oncol. 2022 01 01; 45(1):9-13.
-
Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021 12 16; 7(1):91.
-
Multimodal Therapy Including Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Can Result in Long-term Disease-free Survival in Pediatric Desmoplastic Small Round Cell Tumor With Extraperitoneal Disease. J Pediatr Hematol Oncol. 2021 08 01; 43(6):228-231.
-
ASO Author Reflections: Disparities in Access to Cytoreductive Surgery. Ann Surg Oncol. 2021 11; 28(12):7807-7808.
-
Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer. Ann Surg Oncol. 2021 Nov; 28(12):7795-7806.